Pharmacological applications of antioxidants: lights and shadows

L Saso, O Firuzi - Current Drug Targets, 2014 - ingentaconnect.com
Oxidative stress is linked with many pathologies ranging from cancer to neurodegenerative
disorders and antioxidants have presumably therapeutic value in such diseases. In this …

[HTML][HTML] Acetyltransferases (HATs) as targets for neurological therapeutics

A Schneider, S Chatterjee, O Bousiges, BR Selvi… - …, 2013 - Elsevier
The acetylation of histone and non-histone proteins controls a great deal of cellular
functions, thereby affecting the entire organism, including the brain. Acetylation …

Nuclear poly (ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

L McGurk, J Mojsilovic-Petrovic, VM Van Deerlin… - Acta neuropathologica …, 2018 - Springer
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal motor neuron disease.
Diagnosis typically occurs in the fifth decade of life and the disease progresses rapidly …

[PDF][PDF] Age-related neurodegenerative disease research needs aging models

IP Johnson - Frontiers in aging neuroscience, 2015 - Citeseer
We all know that age-related neurodegenerative diseases affect aging individuals. So why
does basic research continue to make use of the immature nervous system or mutants that …

Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis

HM Vesterinen, P Connick, CMJ Irvine, ES Sena… - PloS one, 2015 - journals.plos.org
Objective To develop and implement an evidence based framework to select, from drugs
already licenced, candidate oral neuroprotective drugs to be tested in secondary …

Ablation of C9orf72 together with excitotoxicity induces ALS in rats

W Dong, Y Ma, F Guan, X Zhang, W Chen… - The FEBS …, 2021 - Wiley Online Library
Pathogenesis of familial amyotrophic lateral sclerosis (ALS) linked to expansion of the
chromosome 9 open reading frame 72 (C9orf72) hexanucleotide repeat that impairs …

Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis–vulnerability of lower motor neurons to proximal excitotoxicity

CA Blizzard, KA Southam, E Dawkins… - Disease models & …, 2015 - journals.biologists.com
There is a desperate need for targeted therapeutic interventions that slow the progression of
amyotrophic lateral sclerosis (ALS). ALS is a disorder with heterogeneous onset, which then …

Spinal inhibitory circuits and their role in motor neuron degeneration

UN Ramírez-Jarquín, R Lazo-Gómez… - …, 2014 - Elsevier
In the spinal cord neuronal activity is controlled by the balance between excitatory and
inhibitory neurotransmission, mediated mainly by the neurotransmitters glutamate and …

Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease

A Rando, D Pastor, MC Viso-León, A Martínez… - Stem cell research & …, 2018 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder
characterized by progressive muscle weakness, paralysis and death. There is no effective …

[HTML][HTML] Neurotrophic peptides: potential drugs for treatment of amyotrophic lateral sclerosis and Alzheimer's disease

J Ciesler, Y Sari - Open journal of neuroscience, 2013 - ncbi.nlm.nih.gov
Neurodegenerative diseases are characterized by the progressive loss of neurons and glial
cells in the central nervous system correlated to their symptoms. Among these …